Doctor Ola Vedin
Uppsala University, Uppsala (Sweden)
Early real-world implementation of sacubitril/valsartan in Sweden
Event: Heart Failure 2018
Topic: Pharmacotherapy
Session: Chronic Heart Failure – Treatment
Prevalence and prognostic implications of longitudinal ejection fraction change in heart failure
Event: Heart Failure 2018
Topic: Epidemiology, Prognosis, Outcome
Session: Diagnostics - From epicardial fatty tissue to biomarkers and echocardiography
Significance of ischemic heart disease in patients with heart failure with preserved, mid-range and reduced ejection fraction - A nationwide cohort study
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Chronic pulmonary hypertension
Session: Rapid Fire 4 - Therapy and management
ESC 365 is supported by
